4390-16-3

Basic information

• Product Name: SODIUM BARBITURATE
• Synonyms: 2,4,6(1H,2H,5H)-Pyrimidinetrione,monosodiumsalt;2,4,6(1h,3h,5h)-pyrimidinetrione,monosodiumsalt;barbituricacid,monosodiumsalt;monosodiumbarbiturate;SODIUM BARBITURATE;BARBITURIC ACID SODIUM SALT;Barbituric acid sodium;2-Sodiooxy-4,6(1H,5H)-pyrimidinedione
• CAS NO: 4390-16-3
• Molecular Formula: C₄H₃N₂O₃*Na
• Molecular Weight: 150.07
• EINECS: 224-507-3
• Mol File: 4390-16-3.mol
• Article Data: 1

Chemical Properties

• Boiling Point: °Cat760mmHg
• Flash Point: °C
• Appearance: /
• Density: 1.455g/cm³
• Storage Temp.: Store below +30°C.
• Solubility: H2O: 20 mg/mL, clear
• BRN: 3748030
• CAS DataBase Reference: SODIUM BARBITURATE(CAS DataBase Reference)
• NIST Chemistry Reference: SODIUM BARBITURATE(4390-16-3)
• EPA Substance Registry System: SODIUM BARBITURATE(4390-16-3)

Safety Data

• Safety Statements: 22-24/25
• WGK Germany: 3
• RTECS: CQ7280000
• Hazardous Substances Data: 4390-16-3(Hazardous Substances Data)

Usage

Chemical Properties

White to yellow-tinted powder. Soluble in water and dilute mineral acid, p H of a 1% aqueous solution 10.5.

Uses

Different sources of media describe the Uses of 4390-16-3 differently. You can refer to the following data:
1. Sodium barbiturate has been used for quantification of thrombin in plasma. It has been used in the estimation of trypsin in duodenal contents. It was also used as a buffer to characterise the functions of two long-chain fatty acid CoA ligase genes (facl) in crude oil-degrading Geobacillus thermodenitrificans NG80-2.
2. Synthetic intermediate, catalyst in ammonium nitrate propellants, wood impregnating solutions.

General Description

Sodium barbiturate is a white to light beige powder. It accelerates the propagation of metastatic prostate adenocarcinomas in rats and in tissue culture.

Hazard

Toxic by ingestion.

InChI:InChI=1/C4H4N2O3.Na/c7-2-1-3(8)6-4(9)5-2;/h1H2,(H2,5,6,7,8,9);/q;+1

Upstream product

• 67-52-7 BARBITURIC ACID 

Relevant articles and documents

ANTIMICROBIAL SILVER COMPOSITIONS

The present invention comprises methods and compositions for antimicrobial silver compositions comprising silver nanoparticles. The present invention further comprises compositions for preparing silver nanoparticles comprising at least one stabilizing agent, one or more silver compounds, at least one reducing agent and a solvent. In one aspect, the stabilizing agent comprises a surfactant or a polymer. The polymer may comprise polymers such as polyacrylamides, polyurethanes, and polyamides. In one aspect, the silver compound comprises a salt comprising a silver cation and an anion. The anion may comprise saccharinate derivatives, long chain fatty acids, and alkyl dicarboxylates. The methods of the present invention comprise treating devices with the silver nanoparticle compositions, including, but not limited to, such devices as woven wound care materials, catheters, patient care devices, and collagen matrices. The present invention further comprises treatment of humans and animals wacr6ith the antimicrobial devices described herein.